ebook img

Hematologic malignancies: acute leukemias PDF

301 Pages·2008·13.56 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Hematologic malignancies: acute leukemias

E.H. Estey · S.H. Faderl · H.M. Kantarjian Hematologic Malignancies: Acute Leukemias E.H. Estey · S.H. Faderl · H.M. Kantarjian Hematologic Malignancies: Acute Leukemias With 44 Figures and 51 Tables (cid:2) (cid:3) E.H. Estey H.M. Kantarjian Departmentof Leukemia Departmentof Leukemia The Universityof Texas The Universityof Texas MDAndersonCancer Center MDAndersonCancer Center Houston, Texas, USA Houston, Texas, USA S.H. Faderl Departmentof Leukemia The Universityof Texas MDAndersonCancer Center Houston, Texas, USA ISBN 978-3-540-72302-8 SpringerBerlinHeidelbergNewYork LibraryofCongressControlNumber:2007932731 Thisworkissubjecttocopyright.Allrightsarereserved,whetherthewholeorpartofthematerialisconcerned,specifically therightsoftranslation,reprinting,reuseofillustrations,recitation,broadcasting,reproductiononmicrofilmorinanyother way,andstorageindatabanks.Duplicationofthispublicationorpartsthereofispermittedonlyundertheprovisionsofthe GermanCopyrightLawofSeptember9, 1965, in its currentversion,andpermissionfor usemust always be obtainedfrom Springer-Verlag.ViolationsareliableforprosecutionundertheGermanCopyrightLaw. SpringerisapartofSpringerScience+BusinessMedia springer.com ©SpringerBerlinHeidelberg2008 The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absenceofaspecificstatement,thatsuchnamesareexemptfromtherelevantprotectivelawsandregulationsandtherefore freeforgeneraluse. Product liability: The publishers cannotguaranteethe accuracyofany information about the applicationofoperative tech- niquesandmedicationscontainedinthisbook.Ineveryindividualcasetheusermustchecksuchinformationbyconsulting therelevantliterature. Editor:Dr.UteHeilmann,Heidelberg,Germany Deskeditor:MeikeStoeck,Heidelberg,Germany Production:LE-TEXJelonek,Schmidt&VöcklerGbR,Leipzig,Germany Typesetting:K+VFotosatzGmbH,Beerfelden,Germany Coverdesign:ErichKirchner,Heidelberg,Germany 21/3180/YL–5 4 3 2 1 0–Printedonacid-freepaper Table of Contents Part I – Acute Myeloid Leukemia 8 Diagnosis of AcuteLymphoblastic Leukemia . . . . . . . . . . . . . . . . . 119 1 Therapy of AML . . . . . . . . . . . . 1 M. Albitar, F.J. Giles, H. Kantarjian E.H. Estey 9 General Approach to the Therapy 2 Diagnosis and Classification of of Adult Acute Lymphoblastic the Acute Myeloid Leukemias Leukemia . . . . . . . . . . . . . . . . . 131 (with Discussion of the Role of S.H. Faderl, H.M. Kantarjian the Myelodysplastic Syndromes in AML Pathogenesis) . . . . . . . . 21 10 Recent Clinical Trials in Acute D. Head, M.A. Thompson Lymphoblastic Leukemia by the Cancer and Leukemia Group B . 137 3 Acute Myeloid Leukemia: R.A. Larson, D. Yu, B.L. Sanford, Epidemiology and Etiology . . . . 47 W. Stock B. Deschler, M. Lübbert 4 Relapsed and Refractory Acute 11 Conventional Therapy in Adult Myeloid Leukemia . . . . . . . . . . 57 Acute Lymphoblastic Leukemia: S. Abutalib, M.S. Tallman Review of the LALA Program . . 145 X. Thomas, D. Fiere PartII–AcuteLymphoblasticLeukemia 12 ALLTherapy: Review of the MD Anderson Program . . . . . . . . . . 161 5 Acute Lymphoblastic Leukemia: S.H. Faderl, D.A. Thomas, Epidemiology and Etiology . . . . 77 H.M. Kantarjian D. Wartenberg, F.D. Groves, A.S. Adelman 13 TreatmentofAdultALLAccording to Protocols of the German 6 Molecular Biology and Genetics 95 Multicenter Study Group for M. Wetzler, M. Kryzstof Adult ALL (GMALL) . . . . . . . . . . 167 7 Acute Lymphoblastic Leukemia: N. Gökbuget, R. Arnold, A. Böhme, Clinical Presentation, Diagnosis, R. Fietkau, M. Freund, A. Ganser, and Classification . . . . . . . . . . . 109 M. Kneba, T. Lipp, W.-D. Ludwig, R.A. Larson, J.Anastasi G. Maschmeyer, D. Messerer, H. Rieder, E. Thiel, D. Hoelzer for the German Multicenter Study Groupfor Adult ALL (GMALL) VI TableofContents 14 Philadelphia Chromosome- 19 Novel Therapies in Acute Positive Acute Lymphoblastic Lymphoblastic Leukemia . . . . . . 237 Leukemia . . . . . . . . . . . . . . . . . . 177 S.H. Faderl, H.M. Kantarjian O. Sala-Torra, J.P. Radich 20 Minimal Residual Disease 15 Burkitt’s Acute Lymphoblastic Studies in Acute Lymphoblastic Leukemia (L3ALL) in Adults . . . . 191 Leukemia . . . . . . . . . . . . . . . . . . 247 V. Ribrag, P. Casassus, P. Fenaux S. Abutalib, W. Stock 16 Treatment of Lymphoblastic 21 Central Nervous System Involve- Lymphoma in Adults . . . . . . . . . 203 ment in Adult Acute Lymphocytic N. Gökbuget, D. Hoelzer Leukemia . . . . . . . . . . . . . . . . . . 263 R.H. Alvarez, J.E. Cortes 17 The Role of Allogeneic Stem Cell Transplantation in the Therapy 22 Relapsed Acute Lymphoblastic of Adult Acute Lymphoblastic Leukemia . . . . . . . . . . . . . . . . . . 275 Leukemia (ALL) . . . . . . . . . . . . . 215 N. Lamanna, M. von Hassel, P. Kebriaei,R. Champlin M. Weiss 18 The Role of Autologous Stem 23 Emergencies in Acute Cell Transplantation in the Man- Lymphoblastic Leukemia . . . . . . 281 agement of Acute Lymphoblastic O. Frankfurt, M.S. Tallman Leukemia in Adults . . . . . . . . . . 229 P. Kebriaei,S. Giralt Subject Index . . . . . . . . . . . . . . . . . . 289 Contributors S. Abutalib A. Böhme Section of Hematology-Oncology Johann WolfgangGoethe-University UniversityofIllinois Medical Department II Chicago, IL, USA Frankfurt, Germany A.S. Adelman P. Casassus Departmentof Biostatistics, Bioinformatics Service d’hématologie clinique and Epidemiology Hôpital Avicennes Medical Universityof South Carolina Université Paris XIII Charleston, SC, USA Bobigny, France M. Albitar R. Champlin Quest Diagnostics Nichols Institute Departmentof Blood San Juan Capistrano, CA, USA and Marrow Transplantation UniversityofTexas R.H. Alvarez M.D. AndersonCancer Center Departmentof Cancer Medicine, Unit 10 Houston, TX, USA UniversityofTexas M.D. AndersonCancer Center J.E. Cortes Houston, TX, USA Departmentof Leukemia The Universityof Texas J. Anastasi M.D. AndersonCancer Center Section of Hematology/Oncology Houston, TX, USA Departmentof Medicine and Departmentof Pathology B. Deschler Cancer Research Center Medical Center UniversityofChicago Departmentof Hematology and Oncology Chicago, IL, USA UniversityofFreiburg Freiburg, Germany R. Arnold Johann WolfgangGoethe-University E.H. Estey Medical Department II Departmentof Leukemia Frankfurt, Germany UniversityofTexas M.D. AndersonCancer Center Houston, TX, USA VIII Contributors S.H. Faderl F.D. Groves Departmentof Leukemia Departmentof Epidemiology The Universityof Texas and Population Health M.D. AndersonCancer Center SchoolofPublicHealthandInformationSciences Houston, TX, USA UniversityofLouisville Louisville, KY, USA P. Fenaux Service d’hématologie clinique D. Head Hôpital Avicennes Departmentof Pathology Université Paris XIII VanderbiltUniversity School ofMedicine Bobigny, France Nashville, TN, USA D. Fiere D. Hoelzer Groupe d’Etude etde Traitementde la Leucémie Johann WolfgangGoethe-University Aiguë Lymphoblastique de l’Adulte Medical Department II (GET-LALAGroup) Frankfurt, Germany Hematology Department H.M. Kantarjian EdouardHerriotHospital Departmentof Leukemia Lyon, France The Universityof Texas R. Fietkau M.D. AndersonCancer Center Johann WolfgangGoethe-University Houston, TX, USA Medical Department II P. Kebriaei Frankfurt, Germany Section of Blood and Marrow Transplantation O. Frankfurt The Universityof Texas Northwestern University Feinberg School M.D. AndersonCancer Center of Medicine Houston, TX, USA Robert H. Lurie Comprehensive Cancer Center M. Kneba Chicago, IL, USA Johann WolfgangGoethe-University M. Freund Medical Department II Johann WolfgangGoethe-University Frankfurt, Germany Medical Department II M. Kryzstof Frankfurt, Germany Division of Hematology and Oncology A. Ganser Arthur G. James Cancer Hospital Johann WolfgangGoethe-University Ohio State University Medical Department II Columbus, OH, USA Frankfurt, Germany N. Lamanna S. Giralt Memorial Sloan-Kettering CancerCenter Section of Blood and Marrow Transplantation New York, NY, USA The Universityof Texas R.A. Larson M.D. AndersonCancer Center Section of Hematology/Oncology Houston, TX, USA Departmentof Medicine N. Gökbuget and Departmentof Pathology Johann WolfgangGoethe-University Cancer Research Center Medical Department II UniversityofChicago Frankfurt, Germany Chicago, IL, USA a Contributors IX T. Lipp B.L. Sanford Johann WolfgangGoethe-University Section of Hematology/Oncology Medical Department II Departmentof Medicine Frankfurt, Germany and Departmentof Pathology Cancer Research Center M. Lübbert UniversityofChicago Medical Center Chicago, IL, USA Departmentof Hematology and Oncology UniversityofFreiburg W. Stock Freiburg, Germany Departmentof Medicine and University of Chicago Cancer Research Center W.D. Ludwig Chicago, IL, USA Johann WolfgangGoethe-University Medical Department II M.S. Tallman Frankfurt, Germany Division of Hematology-Oncology Departmentof Medicine G. Maschmeyer Northwestern University, Johann WolfgangGoethe-University Feinberg School ofMedicine Medical Department II Chicago, IL, USA Frankfurt, Germany E. Thiel D. Messerer Johann WolfgangGoethe-University Johann WolfgangGoethe-University Medical Department II Medical Department II Frankfurt, Germany Frankfurt, Germany D.A. Thomas J.P. Radich Departmentof Leukemia Clinical Research Division The Universityof Texas Fred Hutchinson Cancer Research Center M.D. AndersonCancer Center Seattle, WA, USA Houston, TX, USA V. Ribrag X. Thomas Service d’hématologie Groupe d’Etude etde Traitementde la Leucémie Institut Gustave Roussy Aiguë Lymphoblastique de l’Adulte Villejuif, France (GET-LALAGroup) H. Rieder Hematology Department EdouardHerriotHospital Johann WolfgangGoethe-University Lyon, France Medical Department II Frankfurt, Germany M. von Hassell O. Sala-Torra Memorial Sloan-Kettering CancerCenter New York, NY, USA Clinical Research Division Fred Hutchinson Cancer Research Center M.A. Thompson Seattle, WA, USA Departmentof Pathology VanderbiltUniversity School ofMedicine Nashville, TN, USA X Contributors D. Wartenberg D. Yu Departmentof Environmental Section of Hematology/Oncology and Occupational Medicine Departmentof Medicine Robert Wood Johnson Medical School and Departmentof Pathology Piscataway, NJ, USA Cancer Research Center UniversityofChicago M. Weiss Chicago, IL, USA Memorial Sloan-Kettering CancerCenter New York, NY, USA M. Wetzler Roswell Park Cancer Institute Elm and Carlton Streets Buffalo, NY, USA

Description:
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several chapters in this volume describe current knowledge of acute leukemia biology and discuss new classification systems that have arisen consequent
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.